04:47 AM EDT, 04/24/2024 (MT Newswires) -- Centessa Pharmaceuticals ( CNTA ) said late Tuesday it priced an underwritten public offering of about 10.8 million American depositary shares at $9.25 per ADS for expected gross proceeds of about $100 million.

Underwriters have been granted a 30-day option to purchase up to about 1.6 million additional ADSs.

Closing of the offering is expected to occur around April 26, subject to customary closing conditions.

Centessa was up more than 1% in recent premarket activity on Wednesday.

Price: 9.56, Change: +0.16, Percent Change: +1.70